Skip to main content
    R

    Regenxbio Inc (RGNX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.24
    -0.08 (-1.09%)

    Market Cap: $505.18M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Regenxbio Inc (RGNX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Regenxbio (RGNX) has a latest price of $7.24 on Nov 17, 2026, 55.3% below its 52-week high of $16.19. Its price fell 37.1% over the past 12 months. The month-end price fell 54.3% over the 10 years through Oct 2026, a compound annual decline of 7.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $75.50 in Sep 2018 and its lowest $6.57 in Feb 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RGNX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RGNX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 39.8%, and over 6 months it rose 27.9%. The month-end price fell 44.1% over the 3 years through Oct 2026, a compound annual decline of 17.6%.

    PeriodChange
    1 month+1.3%
    3 months-39.8%
    6 months+27.9%
    12 months-37.1%
    12 months, with dividends-37.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-44.1%-17.6%
    5 years-79.7%-27.3%
    10 years-54.3%-7.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 86.3%, and its weakest was 2024, when it fell 56.9%.

    YearCloseChange
    2026 through Oct 2026$7.20-50.0%
    2025$14.40+86.3%
    2024$7.73-56.9%
    2023$17.95-20.9%
    2022$22.68-30.6%
    2021$32.70-27.9%
    2020$45.36+10.7%
    2019$40.97-2.3%
    2018$41.95+26.2%
    2017$33.25+79.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.7% below its 50-day average of $7.59 and 18.1% below its 200-day average of $8.84.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.24
    52-week high$16.19-55.3%
    52-week low$5.46+32.6%
    50-day average$7.59-4.7%
    200-day average$8.84-18.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 78.4%.

    MeasureValue
    1-year beta1.81
    Largest fall, 1 year-64.6%
    Largest fall, 3 years-78.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RGNX

    What is RGNX's 1-year price change?

    Regenxbio's price fell 37.1% over the past 12 months. With dividends included, the 12-month total return was -37.1%.

    What is RGNX's 5-year price change?

    Regenxbio's month-end price fell 79.7% over the 5 years through Oct 2026, a compound annual decline of 27.3%. These figures leave out dividends.

    What is RGNX's 52-week high and low?

    Regenxbio's 52-week high is $16.19 and its 52-week low is $5.46. Its latest price of $7.24 on Nov 17, 2026 is 55.3% below the high.

    What is RGNX's beta?

    Regenxbio's 1-year beta against the S&P 500 is 1.81, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 64.6%.

    Is the RGNX chart free?

    Yes. Advanced Charting for RGNX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.